RecruitingNCT06436092

Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)


Sponsor

TCROSS Co., Ltd.

Enrollment

280 participants

Start Date

May 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

JDEPTH-LM Registry is a prospective, observational, multi-center study designed for the efficacy and safety of Double-effect kissing balloon technique (W-KBT) in left main (LM) bifurcation percutaneous coronary intervention (PCI) using Perfusion balloon (PB) and Drug coated balloon (DCB) in patients with left main coronary artery disease (LMD) with left circumflex artery (LCx) ostium stenosis.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Age ≥ 18 years
  • Patient with stable coronary artery disease, non-ST-elevation myocardial infarction, or unstable angina
  • Left main disease confirmed by coronary angiography or coronary CT angiography
  • Clinical and anatomical eligibility for PCI as agreed by the local Heart Team
  • Patient with consent prior to undergoing PCI
  • Left main Medina classification (1,1,1), (1,0,1), (0,1,1), (0,0,1) confirmed by coronary angiography
  • De novo target lesion in LMT-LAD amenable for crossover stenting with provisional side-branch approach as determined by PCI operator
  • De novo ostial LCx lesions
  • Lesion indicated in No. 8 with a length of less than 10 mm or a stenosis of less than 70% confirmed by coronary angiography

Exclusion Criteria8

  • Inability to provide written informed consent
  • Patient with a history of ST-elevation myocardial infarction within the previous 1 week
  • Patient in a state of cardiogenic shock
  • Patient with a history of coronary artery bypass grafting
  • Patient with malignant tumors or other conditions with a life expectancy of less than one year
  • Patient considered suitable for stent placement in the ostial LCx from a medical perspective
  • Patient considered unsuitable for anti-thrombotic therapy after PCI
  • Other patient whom the investigator deems unsuitable for the safe conduct of LM-PCI, including W-KBT

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(32)

Ichinomiya Municipal Hospital

Ichinomiya, Aichi-ken, Japan

Fujita Health University School of Medicine

Toyoake, Aichi-ken, Japan

Chiba University Hospital

Chiba, Chiba, Japan

New Tokyo Hospital

Matsudo, Chiba, Japan

Tokyo Bay Urayasu Ichikawa Medical Center

Urayasu, Chiba, Japan

Ehime Prefectural Central Hospital

Matsuyama, Ehime, Japan

Fukuoka Wajiro Hospital

Fukuoka, Fukuoka, Japan

National Hospital Organization Kyushu Medical Center

Fukuoka, Fukuoka, Japan

Kokura Memorial Hospital

Kitakyushu, Fukuoka, Japan

Gifu Heart Center

Gifu, Gifu, Japan

Gunma University Hospital

Maebashi, Gunma, Japan

Hakodate Municipal Hospital

Hakodate, Hokkaido, Japan

Sapporo Higashi Tokushukai Hospital

Sapporo, Hokkaido, Japan

Tsuchiura Kyodo General Hospital

Tsuchiura, Ibaraki, Japan

Tsukuba Medical Center Hospital

Tsukuba, Ibaraki, Japan

Kanazawa Cardiovascular Hospital

Kanazawa, Ishikawa-ken, Japan

Memorial Heart Center Iwate Medical University

Morioka, Iwate, Japan

Shonan Kamakura General Hospital

Kamakura, Kanagawa, Japan

Kitasato University School of Medicine

Sagamihara, Kanagawa, Japan

Yokosuka Kyosai Hospital

Yokosuka, Kanagawa, Japan

Chikamori Hospital

Kochi, Kochi, Japan

Kumamoto University Hospital

Kumamoto, Kumamoto, Japan

Shinshu University Hospital

Matsumoto, Nagano, Japan

Kurashiki Central Hospital

Kurashiki, Okayama-ken, Japan

Urasoe General Hospital

Urasoe, Okinawa, Japan

The University of Tokyo Hospital

Bunkyo, Tokyo, Japan

Moriyama Memorial Hospital

Edogawa City, Tokyo, Japan

Sakakibara Heart Institute

Fuchū, Tokyo, Japan

Jikei University Katsushika Medical Center

Katsushika-ku, Tokyo, Japan

NTT Medical Center Tokyo

Shinagawa, Tokyo, Japan

Keio University Hospital

Shinjuku, Tokyo, Japan

Japanese Red Cross Wakayama Medical Center

Wakayama, Wakayama, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06436092


Related Trials